Biggest News Aggregation in the World

Aml Targets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aml Targets . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aml Targets Today - Breaking & Trending Today

Uproleselan Plus SOC Targeted Regimens and Chemotherapy Under Investigation in AML - Vimarsana News

Uproleselan Plus SOC Targeted Regimens and Chemotherapy Under Investigation in AML

Published: July 28, 2023

Bhavana “Tina” Bhatnagar, DO, discusses the mechanism of action of uproleselan, the potential efficacy and safety benefits of adding this agent to standard therapeutic regimens in patients with AML, and the importance of considering MRD negativity as an end point in AML clinical trials.

Source: onclive.com

Related Topics:

United States Bhavana Tina Bhatnagar Danielj Deangelo Oncology At West Virginia University Cancer Institute Department Of Medicine At West Virginia University University Of California West Virginia University Medical Oncology West Virginia University Cancer Institute Patients With Acute Myeloid Leukemia Uproleselan Plus Mitoxantrone Nd Cytarabine Uproleselan Plus Mec Or Fludarabine Nd Idarubicin Uproleselan Plus Azacitidine And Venetoclax Patients With Treatment Naïve Aml E Selectin Inhibition In The Aml Tumor Microenvironment Aml Targets

Uproleselan Combinations Contribute to Robust Investigational Profile in AML

Published: April 27, 2023

Michael Andreeff, MD, PhD, discusses the potential benefits of E-selectin inhibition in the AML tumor microenvironment, data that have contributed to the further development of uproleselan in this population, and additional AML targets under investigation that may broaden the treatment landscape.

Source: onclive.com